IN2012DN06393A - - Google Patents

Info

Publication number
IN2012DN06393A
IN2012DN06393A IN6393DEN2012A IN2012DN06393A IN 2012DN06393 A IN2012DN06393 A IN 2012DN06393A IN 6393DEN2012 A IN6393DEN2012 A IN 6393DEN2012A IN 2012DN06393 A IN2012DN06393 A IN 2012DN06393A
Authority
IN
India
Prior art keywords
intestine
individual
present
probiotic composition
non secretor
Prior art date
Application number
Other languages
English (en)
Inventor
Pirjo Wacklin
Jaana Mättö
Harri Mäkivuokko
Original Assignee
Suomen Punainen Risti Veripalvelu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suomen Punainen Risti Veripalvelu filed Critical Suomen Punainen Risti Veripalvelu
Publication of IN2012DN06393A publication Critical patent/IN2012DN06393A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
IN6393DEN2012 2009-12-28 2010-12-28 IN2012DN06393A (enExample)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI20096400A FI20096400A0 (fi) 2009-12-28 2009-12-28 Veriryhmästatuksen käyttö I
US12/843,404 US20110158950A1 (en) 2009-12-28 2010-07-26 Use of blood group status i
PCT/FI2010/051093 WO2011080395A2 (en) 2009-12-28 2010-12-28 Use of blood group status i

Publications (1)

Publication Number Publication Date
IN2012DN06393A true IN2012DN06393A (enExample) 2015-10-02

Family

ID=41462858

Family Applications (1)

Application Number Title Priority Date Filing Date
IN6393DEN2012 IN2012DN06393A (enExample) 2009-12-28 2010-12-28

Country Status (7)

Country Link
US (1) US20110158950A1 (enExample)
EP (1) EP2519255A2 (enExample)
CN (1) CN102781466B (enExample)
BR (1) BR112012016926A2 (enExample)
FI (1) FI20096400A0 (enExample)
IN (1) IN2012DN06393A (enExample)
WO (1) WO2011080395A2 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012013861A2 (en) * 2010-07-26 2012-02-02 Suomen Punainen Risti Veripalvelu Use of blood group status iii
US20150265661A1 (en) * 2012-04-13 2015-09-24 Trustees Of Boston College Prebiotic effect of sialyllactose
CN105385762A (zh) * 2015-12-10 2016-03-09 扬州市扬大康源乳业有限公司 一种快速鉴定双歧杆菌的方法
EP3419630A4 (en) 2016-02-24 2019-11-06 Glycom A/S SYNTHETIC COMPOSITION FOR MICROBIOTA MODULATION

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19826928A1 (de) * 1998-06-17 1999-12-23 Novartis Consumer Health Gmbh Arzneimittel, lebensfähige anaerobe Bakterien enthaltend, die die Sulfatreduktion sulfatreduzierender Bakterien hemmen
US6613549B2 (en) * 2000-02-10 2003-09-02 Urex Biotech, Inc. Probiotic therapy for newborns
AU2002329043A1 (en) * 2001-07-30 2003-02-24 Claudio De Simone Treatment of radiation-induced diarrhea with probiotics
JP4709838B2 (ja) * 2004-08-05 2011-06-29 アニドラル エス．アール．エル． 葉酸産生ビフィドバクテリウム菌株、製剤およびこれらの用途
ITMI20042189A1 (it) * 2004-11-16 2005-02-16 Anidral Srl Composizione a base di batteri probiotici e suo uso nella prevenzione e-o nel trattamento di patologie e-o infezioni respiratorie e nel miglioramento della funzionalita' intestinale
ES2381211T3 (es) * 2006-02-15 2012-05-24 Nestec S.A. Uso del Bifidobacterium longum para prevenir y tratar inflamaciones
WO2009033011A1 (en) * 2007-09-07 2009-03-12 Children's Hospital Medical Center Use of secretor, lewis and sialyl antigen levels as predictors for disease
US20090098088A1 (en) * 2007-10-10 2009-04-16 The Procter & Gamble Company Methods And Kits For The Treatment Of Diverticular Conditions

Also Published As

Publication number Publication date
CN102781466A (zh) 2012-11-14
WO2011080395A2 (en) 2011-07-07
EP2519255A2 (en) 2012-11-07
US20110158950A1 (en) 2011-06-30
WO2011080395A3 (en) 2011-09-15
FI20096400A0 (fi) 2009-12-28
CN102781466B (zh) 2015-11-25
BR112012016926A2 (pt) 2019-09-24

Similar Documents

Publication Publication Date Title
NZ709392A (en) Synergistic bacterial compositions and methods of production and use thereof
PH12012500687A1 (en) Nutritional composition for promoting gut microbiota balance and health
IL215168A0 (en) Compsitions compositions and methods for increasing muscle growth
IL229284A0 (en) Assemblies of matrix material, non-cellular, extracellular, sterile, and methods for their production
MX2018009945A (es) Composiciones y metodos novedosos para el tratamiento de las enfermedades relacionadas con la inmunidad.
WO2012013861A3 (en) Use of blood group status iii
PL2513023T3 (pl) Kompozycje i zastosowania cis-1,1,1,4,4,4-heksafluoro-2-butenu
EP2576578A4 (en) POLYMORPHES OF 2'-O-FUCOSYLLACTOSE AND MANUFACTURE THEREOF
MX2010008943A (es) Productos derivados de rebaudiosido a y metodos para preparar productos derivados de rebaudiosido a.
MX344786B (es) Composiciones y metodos para tratar enfermedad de gaucher.
SG179038A1 (en) Compositions and methods for diagnosing autism spectrum disorders
IL220216A0 (en) Azeotrope-like compositions of cis-1,1,1,4,4,4-hexafluoro-2- butene
IL199781A0 (en) Heat resistant probiotic compositions and healthy food comprising them
MY152437A (en) Oral care compositions
AU331248S (en) Symmetrical dental bilateral bite block
GB0905488D0 (en) Organopolysiloxane compositions and their production
PH12012501705A1 (en) Artificial sweeteners and performance
IN2012DN06392A (enExample)
MX2013000793A (es) Composicion que contiene galacto-oligosacarido y un metodo para producirla.
SI2470166T1 (sl) Novi sestavki 1-(2-(2,4-dimetil-fenislulfanil)-fenil)piperazina
PH12015501099A1 (en) Synbiotic composition and use thereof
EP2490721A4 (en) COMPOSITIONS, TREATMENT PROCEDURES AND DIAGNOSIS OF AUTOIMMUN-MEDIATED ILLNESSES AND METHOD FOR THE PREPARATION OF SUCH COMPOSITIONS
ZA201404537B (en) Method and composition for increasing the proportion of dietary ingredients that are resistant to degradation by ruminal microorganisms
IN2012DN03404A (enExample)
IN2012DN06393A (enExample)